The potential anti-MM activity of T cells in MM was suggested in the past with the observation that levels of CD3, CD4, CD8, and CD19 cell subsets in MM are associated with response to chemotherapy and survival [154]. This evidence concerns the gene CD4 and Miyoshi myopathy.